191 related articles for article (PubMed ID: 19469728)
1. The use of depot naltrexone under legal coercion: the case for caution.
Hall W; Capps B; Carter A
Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
[No Abstract] [Full Text] [Related]
2. Depot naltrexone in lieu of incarceration: a behavioral analysis of coerced treatment for addicted offenders.
Marlowe DB
J Subst Abuse Treat; 2006 Sep; 31(2):131-9. PubMed ID: 16919739
[TBL] [Abstract][Full Text] [Related]
3. Lack of information in naltrexone study.
Rastegar DA
Arch Gen Psychiatry; 2007 Jul; 64(7):865; author reply 865. PubMed ID: 17606820
[No Abstract] [Full Text] [Related]
4. Holidays, triggers, and willpower--is there a role for medications? A commentary on "The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients".
Rosenbloom DL
J Subst Abuse Treat; 2009 Jan; 36(1):7. PubMed ID: 19038694
[No Abstract] [Full Text] [Related]
5. Retention in naltrexone implant treatment for opioid dependence.
Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen O; Waal H
Drug Alcohol Depend; 2010 Sep; 111(1-2):166-9. PubMed ID: 20570059
[TBL] [Abstract][Full Text] [Related]
6. Vivitrex (Alkermes/Cephalon).
Heading CE
Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
[TBL] [Abstract][Full Text] [Related]
7. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
Brewer C
Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398
[No Abstract] [Full Text] [Related]
8. [Long-acting naltrexone--a new way out of opiate addiction?].
Stavseth LS; Kunøe N; Tanum L
Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2231-2. PubMed ID: 24226324
[No Abstract] [Full Text] [Related]
9. Narcotic antagonists: naltrexone progress report: foreword.
Jaffe J
NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
[No Abstract] [Full Text] [Related]
10. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
Degenhardt L; Gibson A; Mattick RP; Hall W
Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
[No Abstract] [Full Text] [Related]
11. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
Martin WR
NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
[No Abstract] [Full Text] [Related]
12. The development of sustained action preparations of narcotic antagonists.
Willette RE
NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
[No Abstract] [Full Text] [Related]
13. Insufficient information in drug-related hospital morbidity study.
Newman RG
Arch Gen Psychiatry; 2009 Mar; 66(3):331; author reply 331-2. PubMed ID: 19255384
[No Abstract] [Full Text] [Related]
14. [Interactions between naltrexone, an opioid antagonist, and opioids administered during general anesthesia].
Tesson B; Bigot-Viale A; Vigue JP; Pierrot M; Granry JC
Ann Fr Anesth Reanim; 1999 Feb; 18(2):230-2. PubMed ID: 10207596
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone as negative reinforcement comments on "A behavioral analysis of coerced treatment for addicted offenders".
Farabee D
J Subst Abuse Treat; 2006 Sep; 31(2):141-2. PubMed ID: 16919740
[No Abstract] [Full Text] [Related]
16. Development of injectable microcapsules for use in the treatment of narcotic addiction.
Thies C
Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):19-20. PubMed ID: 1241971
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone implants as treatment for heroin dependence: part I.
Byrne A; Graham G; Hallinan R; Murnion B
Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
[No Abstract] [Full Text] [Related]
18. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence.
O'Brien CP
Curr Psychiatry Rep; 2005 Oct; 7(5):327-8. PubMed ID: 16216149
[No Abstract] [Full Text] [Related]
19. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
[No Abstract] [Full Text] [Related]
20. Extended-release intramuscular naltrexone: a viewpoint by Falk Kiefer.
Kiefer F
Drugs; 2006; 66(13):1752-3. PubMed ID: 16978039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
